Capricor Therapeutics (CAPR) Return on Sales (2011 - 2025)
Capricor Therapeutics (CAPR) recorded quarterly Return on Sales of 0.04% in Q3 2025, down 60.68% quarter-over-quarter from 0.03% in Q2 2025, and up 1.0% on a YoY basis from 0.04% in Q3 2024.
Capricor Therapeutics (CAPR) Return on Sales (2011 - 2025) Analysis & Trends
Capricor Therapeutics' Return on Sales history runs 15 years deep, the most recent figure standing at 0.04% for Q3 2025.
- In Q3 2025, Return on Sales rose 1.0% year-over-year to 0.04%; the TTM figure through Sep 2025 stood at 0.04% (down 3.0% YoY), while the FY2024 annual figure was 0.02%, down 1.0% from the prior year.
- Return on Sales was 0.04% for Q3 2025 at Capricor Therapeutics, down from 0.03% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.02% in Q4 2024 to a low of 1.26% in Q1 2021.
- Historically, Return on Sales has averaged 0.19% across 5 years, with a median of 0.03% in 2024.
- Biggest YoY gain for Return on Sales was 170 bps in 2021; the steepest drop was 115 bps in 2021.
- A 5-year view of Return on Sales shows it stood at 0.85% in 2021, then surged by 91 bps to 0.08% in 2022, then surged by 99 bps to 0.0% in 2023, then surged by 3644 bps to 0.02% in 2024, then slumped by 277 bps to 0.04% in 2025.
- The last three Return on Sales figures came in at 0.04% (Q3 2025), 0.03% (Q2 2025), and 0.01% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 0.02% |
| Sep 30, 2024 | -0.06% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -0.04% |
| Dec 31, 2021 | -0.85% |
| Sep 30, 2021 | -0.62% |
| Jun 30, 2021 | -0.25% |
| Mar 31, 2021 | -1.26% |
| Dec 31, 2020 | -0.72% |
| Sep 30, 2020 | -2.32% |
| Jun 30, 2020 | -0.70% |